Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Authors / Neil Spooner

Neil Spooner

Neil Spooner is founder and director of Spooner Bioanalytical Solutions and the Senior Editor of Bioanalysis, the journal for the field of regulated quantitative bioanalysis. He is also senior visiting research fellow at the School of Life and Medical Sciences, University of Hertfordshire, UK.

  • Contributions
Techniques & Tools Pharma and Biopharma

Long Live the Microsample

June 16, 2016

When it comes to microsampling for quantitative bioanalysis, the devil is certainly in the details. But we should learn from our mistakes – not retreat back into convention.

1 min read

Long Live the Microsample
Techniques & Tools Pharma and Biopharma

Pharma's DBS Dilemma

May 15, 2013

Advantages of dried blood spot (DBS) analysis for the pharmaceutical industry abound yet analytical and regulatory challenges are hindering widespread uptake. Here, two leading proponents of the approach discuss what can be done to overcome the barriers to its implementation.

1 min read

Pharma's DBS Dilemma

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.